Eli Lilly Claims Experimental Drug Protects Covid-19 Patients


A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts. (Ny Times Science) More More

Similar stories

Coronavirus tracker: AZ's US vaccine trial stuck on pause; FDA to release new guidance on emergency use standards: report - FiercePharma

Coronavirus tracker: AZ's US vaccine trial stuck on pause; FDA to release new guidance on emergency use standards: report  FiercePharma

Posted on 23 September 2020 | 2:30 pm | Google News

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers - Nasdaq

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers  Nasdaq

Posted on 23 September 2020 | 8:05 am | Google News

Roche Alzheimer's drug fails, joining long list of trial flops - Nasdaq

Roche Alzheimer's drug fails, joining long list of trial flops  Nasdaq

Posted on 23 September 2020 | 8:04 am | Google News

U.S. Justice Department to propose changes to internet platforms immunity -- source - Nasdaq

U.S. Justice Department to propose changes to internet platforms immunity -- source  Nasdaq

Posted on 23 September 2020 | 8:03 am | Google News

ANALYSIS-China investors bet on volatility as U.S. presidential election heats up - Nasdaq

ANALYSIS-China investors bet on volatility as U.S. presidential election heats up  Nasdaq

Posted on 23 September 2020 | 2:41 am | Google News

EUR/USD Price Forecast – Euro Hanging Onto Support - Sports Grind Entertainment

EUR/USD Price Forecast – Euro Hanging Onto Support  Sports Grind Entertainment

Posted on 22 September 2020 | 8:07 pm | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info